Skip to content

Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

Melatonin Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03779243
Enrollment
90
Registered
2018-12-19
Start date
2019-01-07
Completion date
2021-08-24
Last updated
2021-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbance, Trauma

Brief summary

The purpose of the study is to test the efficacy of sleep treatment in human patients following traumatic injury. Specifically, the study will determine if treatment consisting of melatonin and education related to sleep habits are effective in treating sleep disturbance and improving sleep quality in Orthopaedic trauma patients. We hope to learn if melatonin and sleep education effectively improve sleep following traumatic injury, and improve outcomes.

Interventions

DIETARY_SUPPLEMENTMelatonin 5mg and Sleep Education

Melatonin 5mg daily and sleep education for 6 weeks following injury or surgery.

OTHERPlacebo

Daily placebo pills for 6 weeks following injury or surgery.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

double-blind

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* New patients visiting the Orthopaedic Trauma Clinic or undergoing orthopaedic surgery in Stanford Hospital following traumatic injury. Accidental traumatic fracture injuries that are operative and non-operative. Must be able to swallow tablets.

Exclusion criteria

* Documented head trauma. Cognitive impairments. Minors. Previously diagnosed sleep disorders. Sleep apnea. Enrolled in another study. Women who are pregnant or may become pregnant or are nursing. Hypertension. Diabetes. Endocrine, autoimmune, depressive, bleeding or seizure disorders.

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in Pittsburgh Sleep Quality Index ScoreBaseline, week 6, and week 129-item self-rated questionnaire that assesses clinical sleep quality and disturbances. Global PSQI scores are sums of the component scores, and range from 0-21. Higher scores indicate worse sleep quality.

Secondary

MeasureTime frameDescription
36-Item Short Form Survey (SF-36) to measure quality of lifeBaseline, week 6, and week 1236-item, patient-reported survey of patient health-related quality of life.The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
Mean Change from Baseline in Pain Scores on the Visual Analog Scale (VAS)Baseline, week 6, and week 12VAS is scored on a continuum from 0-10 indicating no pain to unbearable pain. Higher scores indicate more pain intensity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026